Cannabis Cultivation Network

Learn How To Grow Top Shelf Medicine at Home

Register Ask Question

Families forced to pay £40k for medical cannabis to be part of NHS England review

As part of a review into medical cannabis prescribing on the NHS, 22 families who have had problems accessing the drug since its reclassification will speak to NHS England.


The All Party Parliamentary Group (APPG) on Medical Cannabis under Prescription has said it has put forward 22 families to speak with NHS England as part of its “rapid processes evaluation” of NHS medical cannabis prescribing.

Speaking to The Pharmaceutical Journal, Millie Hinton, secretariat for the APPG, said some of these 22 families have been forced to pay £40,000 a year to access medical cannabis through private prescriptions since the law was changed in November 2018, after their NHS clinicians refused to prescribe it.

On 8 April 2019, health secretary Matt Hancock announced in Parliament that he had asked NHS England to launch an evaluation of medical cannabis prescribing to “address barriers” to its prescription.

According to the APPG, no NHS prescriptions for medical cannabis have been written since it was rescheduled in 2018.

A parliamentary answer from pharmacy minister Seema Kennedy on 8 May 2019 revealed that the review “will be clinically led by the NHS England and NHS Improvement medical director and chief pharmaceutical officer, drawing on further specialist support as required” and will involve interviews with those involved in the prescribing process, including patients, carers and relevant trust staff.

She added that NHS England had been asked to provide an interim report on the evaluation to Hancock “by the end of May 2019”.

Hinton said the end of May deadline was “optimistic”.

She added that many of the families put forward to speak with NHS England have children with severe intractable epilepsy and some have resorted to importing cannabis-based products from abroad through private prescriptions “at the cost of about £40,000 a year”.

Despite patients seeing benefits from medical cannabis acquired privately, “NHS clinicians have refused to provide [it]”.

“We’re hoping this review helps with the understanding exactly what, in all these instances, is stopping clinicians prescribing if you’ve got the evidence in front of you like that,” she said.

But she added that NHS England “have been fairly vague in what the review looks like”, which she said has been “disappointing”.

[source: pharmaceutical-journal.com / published: May 13. 2019]
 

Comments

Growing number of new patients interested in smokable medical marijuana
  • 7
  • 0
FLORIDA - The medical marijuana industry is blooming in the state as more people are applying to get their medical cards. Two months ago...
Do marijuana dispensaries drive up home values? At least one study says yes
  • 8
  • 0
Illinois residents could see their home values increase if the state legalizes recreational marijuana, and the bump could come as soon as a law is...
Does the UK really have medical marijuana?
  • 5
  • 0
Has the UK really legalised medical cannabis? That was certainly how it was reported last winter when Sajid Javid, the Home Secretary, overhauled...
Legalization leaves Canada poised to lead on cannabis research
  • 12
  • 0
Federal gov't announces $24.5M in cannabis research grants. The world is looking to Canada as one of the few places where cannabis research can be...
Driver who took PLACEBO tested positive - some heavy users test negative
  • 20
  • 0
Drug driving tests have been called into question after a driver taking a placebo tested positive to cannabis. University of Sydney researchers...
Top Bottom